CLOSE X
GO

ICICI Pru Pharma Healthcare & Diagnostics (P.H.D) Fund-(G)

very highequitypharma & health care
40.11 0.21(0.53%) NAV as on 25 Nov 2025
-0.79 % 1 M
5.36 % 1 Y
26.93 % 3 Y

Growth Chart of the Scheme vis a vis benchmark (SIP value 10,000)

  • 1M
  • 3M
  • 6M
  • 1Y
  • 3Y
  • 5Y
  • 10Y
  • max

FUND OBJECTIVE

To generate long-term capital appreciation by creating a portfolio that is invested in Equity and Equity related securities of pharma, healthcare, hospitals, diagnostics, wellness and allied companies.However there can be no assurance that the investment objectives of the scheme will be realized.

SCHEME DETAILS

expense_ration-icon Expenses Ratio :

1.87

As on 31 Oct, 2025
age-icon Age :

7 yrs 4 m

Since 13 07 ,2018
exit_load Exit Load :

1%

aum AUM :

6,437.36 Crs

lock_in Lock-in :

1% on or before 15D, Nil after 15D

investing_style Investing Style :

Large Growth

Portfolio_book_value Portfolio Price To Book Value :

5.8

Min_Investment Min. Investment :

SIP 100 & Lumpsum 5000

Scheme_benchmark Scheme Benchmark :

NA

Fund_manager Fund Manager :

Dharmesh Kakkad

LATEST ASSET & PORTFOLIO ALLOCATION

as on Oct 31 ,2025
Others 2.90 %
Equity 97.10 %

TOP HOLDINGS

Sun Pharmaceutical Industries...11.88 %
Dr. Reddy's Laboratories Ltd.9.42 %
Divi's Laboratories Ltd.8.50 %
Aurobindo Pharma Ltd.7.62 %
Cipla Ltd.6.61 %
See All Holding

ALLOCATION BY MARKET CAP

ALLOCATION BY SECTOR

Pharmaceuticals & Drugs83.25
Business Support5.43
Hospital & Healthcare Services3.37
Retailing1.23
Chemicals1.17
See All Sectors

5-YEARS HISTORY

Financial Year2020-20212021-20222022-20232023-20242024-2025
NAV in Rs (as on 31-Mar-2025)17.3519.6918.6430.2036.20
Net Assets(Rs Crores) (as on 31-Mar-2025) 2213.63 2500.42 2594.59 3772.32 4914.64
Scheme Returns(%)(Absolute)83.7912.51-5.3861.1518.22
B'mark Returns(%)(Absolute)NANANANANA
Category Rank19/7547/7563/7612/906/102

RISKOMETER Level of Risk in the Scheme

Investors understand that their principal will be at very high risk

PERFORMANCE COMPARISON WITH SIMILAR SCHEMES

ICICI Pru Pharma Healthcare & Diagnostics (P.H.D) Fund-(G)Very HighEquity40.110.21(0.53%)NAV As on 25 Nov, 202513-Jul-2018Inception Date6,437.36AUM In Cr.5.36%1Y26.93%3Y20.05%5Y20.72%Since Inception
SBI Healthcare Opp Fund-Reg(G)Very HighEquity431.47-0.01(0.00%)NAV As on 25 Nov, 202514-Jul-1999Inception Date4,082.13AUM In Cr.1.87%1Y23.84%3Y18.88%5Y16.06%Since Inception
Nippon India Pharma Fund(G)Very HighEquity514.771.33(0.26%)NAV As on 25 Nov, 202505-Jun-2004Inception Date8,346.49AUM In Cr.0.84%1Y21.35%3Y17.19%5Y20.13%Since Inception
ATTENTION INVESTORS NSDL/CDSL KYC Advisory for investors